| ||
Vivus Sinks After Diet Drug Ingredient Linked to Oral Clefts BusinessWeek Vivus's diet pill, Qnexa, combines topiramate with the appetite suppressant phentermine. The analysis, dubbed Fortress, found the risk of cleft palates or cleft lips was 5.44 times higher for the group in which mothers had taken topiramate alone or in ... See all stories on this topic » | ||
| ||
| ||
|
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment